John Dubinion | Pharmacologist

John Dubinion, Pharmacologist, FDA

John Dubinion is a Master Pharmacologist in the Division of Pharm/Tox for Infectious Diseases (Office of Infectious Diseases/Office of New Drugs/Center for Drug Evaluation and Research/FDA). He reviews nonclinical regulatory submissions for antiviral drugs. He obtained a Ph.D. in Pharmacology at the University of Pittsburgh School of Medicine and started his career in academia in the Physiology Dept. at the University of Mississippi Medical Center. John transitioned from academia to the pharmaceutical industry where he acted as a Research Pharmacologist at Forest Laboratories in Jersey City, NJ. His experience across multiple scientific organizations where he has had to leverage his training in physiology, pharmacology, and toxicology to support business, academia and now regulation, gives him a unique set of skills that benefit teams of multidisciplinary scientists, clinicians, and business/regulatory experts.


Day 1 - November 28 @ 16:50

Panel: Bridging the divide - animal rule to clinical development

  • Use of pre-clinical models to inform licensure
  • Regulatory pathways
  • International coordination on clinical trials
last published: 02/Jan/24 12:15 GMT

back to speakers